EGFR and non-small cell lung carcinoma: Alder et al.[37] analyzed serum ctDNA from 253 patients with BM and found that EGFR alterations were most frequently detected in patients with NSCLC BM (p<0.001) and in those with isolated BM with stable extracranial disease (p = 0.08).